Product Information
PHENYLEPHRINE 10% EYE DROP is a generic product labeled by Paragon BioTeck, Inc., priced at $5.2383 per ML under NDC 42702010305. Its NADAC has been published 53 times since Nov 28, 2013.
FDA first approved this application on Mar 21, 2013. Its Orange Book therapeutic-equivalence code is AT.
Strength
100 mg/mL
Manufacturer
Paragon BioTeck, Inc.NDC
42702010305
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
PHENYLEPHRINE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA203510FDA Approved
3/21/2013
TE Code
AT
On Market Since
4/15/2013
Pharmacological Classes
Price Statistics
The NADAC for PHENYLEPHRINE 10% EYE DROP has been published 53 times since Nov 28, 2013, and over the history we have for it it has risen 504.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.2383 per ML |
|---|---|
| All-time high | $5.3900 (May 13, 2026) |
| All-time low | $0.8666 (Nov 28, 2013) |
| 52-week high | $5.3900 |
| 52-week low | $5.1315 |
| Median price | $0.8666 |
| Average price | $2.8591 |
| Largest weekly change | +522.0% (Apr 22, 2026) |
| Weeks tracked | 53 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the phenylephrine hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Paragon BioTeck, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
phenylephrine hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
alpha-1 Adrenergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PHENYLEPHRINE 10% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for PHENYLEPHRINE 10% EYE DROP, manufactured by Paragon BioTeck, Inc., is $5.2383 per ML (NDC 42702010305), effective Sep 30, 2026.
How has the price of PHENYLEPHRINE 10% EYE DROP changed over time?
Over the history we have for it, the NADAC for PHENYLEPHRINE 10% EYE DROP has risen 504.5%. It has been tracked across 53 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for PHENYLEPHRINE 10% EYE DROP?
Since Nov 28, 2013, the NADAC for PHENYLEPHRINE 10% EYE DROP has ranged from a low of $0.8666 (Nov 28, 2013) to a high of $5.3900 (May 13, 2026), with a median of $0.8666 per ML.
Are there cheaper alternatives to PHENYLEPHRINE 10% EYE DROP?
No other NADAC-published product currently shares the active ingredient and strength of PHENYLEPHRINE 10% EYE DROP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures PHENYLEPHRINE 10% EYE DROP?
PHENYLEPHRINE 10% EYE DROP (NDC 42702010305) is labeled by Paragon BioTeck, Inc., and CMS classifies it as a generic product.